Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,947 public trials 2,015 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, Not Recruiting

Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma

NCT03600441

Conditions
Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Advocate Medical Group - Park Ridge, Luther Lane - Oncology Park Ridge, Illinois, United States
  • Norton Cancer Institute - St. Matthews Campus Louisville, Kentucky, United States
  • Clinical Research Alliance Inc Lake Success, New York, United States
  • Manhattan Hematology Oncology Center New York, United States
View all 15 locations
View Trial Details
Active, Not Recruiting

Study of the Adverse Events and Change in Disease State of Pediatric Participants (and Young Adults Between the Ages of 18-25) With Relapsed/Refractory Aggressive Mature B-cell Neoplasms Receiving Subcutaneous (SC) Injections of Epcoritamab

NCT05206357

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +15 more
Locations
  • Lucile Packard Children's Hospital /ID# 240854 Palo Alto, California, United States
  • Nicklaus Children's Hospital /ID# 241174 Miami, Florida, United States
  • New York Medical College /ID# 239208 Valhalla, New York, United States
  • Levine Children's Hospital /ID# 242765 Charlotte, North Carolina, United States
View all 41 locations
View Trial Details
Active, Not Recruiting

The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation

NCT04233346

Conditions
Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Chronic Disease, +18 more
Locations
  • Anhui Provincial Hospital Hefei, Anhui, China
  • The First Affiliated Hospital of Anhui Medical University Hefei, Anhui, China
  • Nanfang Hospital of Southern Medical University Guangzhou, Guangdong, China
  • Tongji Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 14 locations
View Trial Details
Active, Not Recruiting

Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients

NCT03376672

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Helsinki University Central Hospital Helsinki, Finland
  • Central Finland Central Hospital Jyväskylä, Finland
  • Kainuu Central Hospital Kajaani, Finland
  • Kymenlaakso Central Hospital Kotka, Finland
View all 26 locations
View Trial Details
Active, Not Recruiting

Iberdomide Combined With Low-dose Cyclophosphamide and Dexamethasone

NCT04392037

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • NWZ Alkmaar, Netherlands
  • Amsterdam UMC, location AMC Amsterdam, Netherlands
  • Amsterdam UMC, location VUmc Amsterdam, Netherlands
  • Rijnstate Arnhem, Netherlands
View Trial Details
Active, Not Recruiting

Selinexor With Alternating Bortezomib or Lenalidomide Plus Dexamethasone in TIE Newly Diagnosed MM Patients

NCT04717700

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Aalborg University Hospital Aalborg, Denmark
  • Sydvestjysk Sygehus Esbjerg Esbjerg, Denmark
  • Regionshospitalet Gødstrup Gødstrup, Denmark
  • Odense University Hospital Odense, Denmark
View Trial Details
Active, Not Recruiting

A Trial for Relapsed Multiple Myeloma Patients (Isatuximab-dexamethasone)

NCT04965155

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • AOU Ospedali Riuniti Umberto I Ancona, Italy
  • AOU Policlinico di Bari Bari, Italy
  • AOU di Bologna Bologna, Italy
  • Ospedale di Bolzano - Azienda Sanitaria dell'Alto Adige Bolzano, Italy
View all 14 locations
View Trial Details

Related conditions